Schedule 13G ownership disclosure

SYNERGY PHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 871639308

Event date: 2015-10-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,946,624
Percent of class
5.0200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-15-003867
Form type
SC 13G
Filer
Tetragon Partners GP Ltd
CIK
CIK 1515070
Filed
Oct 09, 2015
Reporting period
Oct 01, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub